Jane Street Group LLC Has $19.68 Million Position in Integer Holdings Co. (NYSE:ITGR)

Jane Street Group LLC grew its position in Integer Holdings Co. (NYSE:ITGR) by 23.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 151,397 shares of the medical equipment provider’s stock after purchasing an additional 28,572 shares during the quarter. Jane Street Group LLC’s holdings in Integer were worth $19,682,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Contravisory Investment Management Inc. grew its stake in Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 80 shares during the last quarter. Huntington National Bank lifted its position in Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after acquiring an additional 268 shares during the last quarter. Quest Partners LLC boosted its holdings in Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 332 shares during the period. GAMMA Investing LLC grew its position in shares of Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock valued at $85,000 after purchasing an additional 278 shares during the last quarter. Finally, Innealta Capital LLC bought a new position in shares of Integer in the second quarter worth about $110,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Citigroup increased their target price on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Benchmark increased their price objective on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. Bank of America boosted their target price on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Truist Financial reduced their price target on shares of Integer from $150.00 to $147.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, KeyCorp boosted their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a report on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $142.00.

Integer Price Performance

NYSE:ITGR opened at $138.25 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The company has a 50-day moving average of $132.80 and a 200-day moving average of $125.29. Integer Holdings Co. has a 52 week low of $89.65 and a 52 week high of $142.76. The company has a market capitalization of $4.64 billion, a price-to-earnings ratio of 42.67, a PEG ratio of 2.00 and a beta of 1.12.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The company had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.27 earnings per share. As a group, equities research analysts anticipate that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.